Literature DB >> 23941420

Distinct activation phenotype of a highly conserved novel HLA-B57-restricted epitope during dengue virus infection.

Elizabeth Townsley1, Marcia Woda, Stephen J Thomas, Siripen Kalayanarooj, Robert V Gibbons, Ananda Nisalak, Anon Srikiatkhachorn, Sharone Green, Henry A F Stephens, Alan L Rothman, Anuja Mathew.   

Abstract

Variation in the sequence of T-cell epitopes between dengue virus (DENV) serotypes is believed to alter memory T-cell responses during second heterologous infections. We identified a highly conserved, novel, HLA-B57-restricted epitope on the DENV NS1 protein. We predicted higher frequencies of B57-NS1(26-34) -specific CD8(+) T cells in peripheral blood mononuclear cells from individuals undergoing secondary rather than primary DENV infection. However, high tetramer-positive T-cell frequencies during acute infection were seen in only one of nine subjects with secondary infection. B57-NS1(26-34) -specific and other DENV epitope-specific CD8(+) T cells, as well as total CD8(+) T cells, expressed an activated phenotype (CD69(+) and/or CD38(+)) during acute infection. In contrast, expression of CD71 was largely limited to DENV epitope-specific CD8(+) T cells. In vitro stimulation of cell lines indicated that CD71 expression was differentially sensitive to stimulation by homologous and heterologous variant peptides. CD71 may represent a useful marker of antigen-specific T-cell activation.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  CD71; CD8+ T cells; HLA-B57; dengue; transferrin

Mesh:

Substances:

Year:  2014        PMID: 23941420      PMCID: PMC3893847          DOI: 10.1111/imm.12161

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  44 in total

Review 1.  HIV-1 diversity versus HLA class I polymorphism.

Authors:  Henry A F Stephens
Journal:  Trends Immunol       Date:  2005-01       Impact factor: 16.687

2.  Serological and virological features of dengue fever and dengue haemorrhagic fever in Thailand from 1999 to 2002.

Authors:  S Anantapreecha; S Chanama; A A-nuegoonpipat; S Naemkhunthot; A Sa-Ngasang; P Sawanpanyalert; I Kurane
Journal:  Epidemiol Infect       Date:  2005-06       Impact factor: 2.451

3.  Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection.

Authors:  A Mathew; I Kurane; S Green; H A Stephens; D W Vaughn; S Kalayanarooj; S Suntayakorn; D Chandanayingyong; F A Ennis; A L Rothman
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Four dengue virus serotypes found circulating during an outbreak of dengue fever and dengue haemorrhagic fever in Jakarta, Indonesia, during 2004.

Authors:  Agus Suwandono; Herman Kosasih; Rita Kusriastuti; Syahrial Harun; Chairin Ma'roef; Suharyono Wuryadi; Bambang Herianto; Djoko Yuwono; Kevin R Porter; Charmagne G Beckett; Patrick J Blair
Journal:  Trans R Soc Trop Med Hyg       Date:  2006-02-28       Impact factor: 2.184

Review 5.  Secretion of flaviviral non-structural protein NS1: from diagnosis to pathogenesis.

Authors:  S Alcon-LePoder; P Sivard; M T Drouet; A Talarmin; C Rice; M Flamand
Journal:  Novartis Found Symp       Date:  2006

6.  Cross-reactive memory CD8(+) T cells alter the immune response to heterologous secondary dengue virus infections in mice in a sequence-specific manner.

Authors:  Coreen M Beaumier; Anuja Mathew; Hema S Bashyam; Alan L Rothman
Journal:  J Infect Dis       Date:  2008-02-15       Impact factor: 5.226

7.  Viral replication and paracrine effects result in distinct, functional responses of dendritic cells following infection with dengue 2 virus.

Authors:  Zachary D Nightingale; Chinmay Patkar; Alan L Rothman
Journal:  J Leukoc Biol       Date:  2008-07-23       Impact factor: 4.962

8.  Transferrin receptor in T cell activation and transplantation.

Authors:  A L Bayer; P Baliga; J E Woodward
Journal:  J Leukoc Biol       Date:  1998-07       Impact factor: 4.962

9.  Protective and enhancing HLA alleles, HLA-DRB1*0901 and HLA-A*24, for severe forms of dengue virus infection, dengue hemorrhagic fever and dengue shock syndrome.

Authors:  Thi Phuong Lan Nguyen; Mihoko Kikuchi; Thi Que Huong Vu; Quang Ha Do; Thi Thuy Tran; Dinh Tham Vo; Manh Tuan Ha; Van Tuong Vo; Thi Phi Nga Cao; Van Dat Tran; Toshifumi Oyama; Kouichi Morita; Michio Yasunami; Kenji Hirayama
Journal:  PLoS Negl Trop Dis       Date:  2008-10-01

10.  HLA alleles associated with slow progression to AIDS truly prefer to present HIV-1 p24.

Authors:  José A M Borghans; Anne Mølgaard; Rob J de Boer; Can Keşmir
Journal:  PLoS One       Date:  2007-09-19       Impact factor: 3.240

View more
  11 in total

Review 1.  Immune-mediated cytokine storm and its role in severe dengue.

Authors:  Anon Srikiatkhachorn; Anuja Mathew; Alan L Rothman
Journal:  Semin Immunopathol       Date:  2017-04-11       Impact factor: 9.623

Review 2.  Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.

Authors:  Anuja Mathew; Elizabeth Townsley; Francis A Ennis
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

Review 3.  CD4+ and CD8+ T-cell immunity to Dengue - lessons for the study of Zika virus.

Authors:  Laura Rivino; Mei Qiu Lim
Journal:  Immunology       Date:  2016-11-27       Impact factor: 7.397

4.  Immunopathogenesis Versus Protection in Dengue Virus Infections.

Authors:  Alan L Rothman; Carey L Medin; Heather Friberg; Jeffrey R Currier
Journal:  Curr Trop Med Rep       Date:  2014-03-01

Review 5.  T lymphocyte responses to flaviviruses - diverse cell populations affect tendency toward protection and disease.

Authors:  Luis Alberto Sanchez Vargas; Anuja Mathew; Alan L Rothman
Journal:  Curr Opin Virol       Date:  2020-08-15       Impact factor: 7.090

6.  Peripheral Follicular T Helper Cells and Mucosal-Associated Invariant T Cells Represent Activated Phenotypes During the Febrile Phase of Acute Dengue Virus Infection.

Authors:  Sathappan U Preeyaa; Amudhan Murugesan; Surliappan Sopnajothi; Yean K Yong; Hong Y Tan; Marie Larsson; Vijayakumar Velu; Esaki M Shankar
Journal:  Viral Immunol       Date:  2020-09-30       Impact factor: 2.257

7.  Interaction of a dengue virus NS1-derived peptide with the inhibitory receptor KIR3DL1 on natural killer cells.

Authors:  E Townsley; G O'Connor; C Cosgrove; M Woda; M Co; S J Thomas; S Kalayanarooj; I-K Yoon; A Nisalak; A Srikiatkhachorn; S Green; H A F Stephens; E Gostick; D A Price; M Carrington; G Alter; D W McVicar; A L Rothman; A Mathew
Journal:  Clin Exp Immunol       Date:  2015-11-24       Impact factor: 4.330

Review 8.  Development of Peptide Vaccines in Dengue.

Authors:  Kavita Reginald; Yanqi Chan; Magdalena Plebanski; Chit Laa Poh
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

Review 9.  Human T Cell Response to Dengue Virus Infection.

Authors:  Yuan Tian; Alba Grifoni; Alessandro Sette; Daniela Weiskopf
Journal:  Front Immunol       Date:  2019-09-04       Impact factor: 7.561

10.  Inferring Protective CD8+ T-Cell Epitopes for NS5 Protein of Four Serotypes of Dengue Virus Chinese Isolates Based on HLA-A, -B and -C Allelic Distribution: Implications for Epitope-Based Universal Vaccine Design.

Authors:  Jiandong Shi; Jing Sun; Meini Wu; Ningzhu Hu; Jianfan Li; Yanhan Li; Haixuan Wang; Yunzhang Hu
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.